DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,159,540 | +148.2% | 363,400 | +140.1% | 0.26% | +143.5% |
| Q2 2023 | $36,325,440 | -79.1% | 151,356 | -78.0% | 0.11% | -79.9% |
| Q1 2023 | $173,699,919 | +135.4% | 689,176 | +141.3% | 0.54% | +82.4% |
| Q3 2022 | $73,774,000 | +117.1% | 285,623 | +113.1% | 0.30% | +106.3% |
| Q2 2022 | $33,979,000 | +12.7% | 134,027 | +30.4% | 0.14% | +19.2% |
| Q1 2022 | $30,149,000 | +31.3% | 102,782 | +47.3% | 0.12% | +30.4% |
| Q4 2021 | $22,963,000 | +86.5% | 69,795 | +72.6% | 0.09% | +70.4% |
| Q3 2021 | $12,314,000 | -48.9% | 40,449 | -54.9% | 0.05% | -50.0% |
| Q2 2021 | $24,080,000 | -67.7% | 89,732 | -72.9% | 0.11% | -69.0% |
| Q1 2021 | $74,541,000 | -23.9% | 331,177 | -24.9% | 0.35% | -27.2% |
| Q4 2020 | $97,900,000 | -16.2% | 440,712 | -18.8% | 0.48% | -20.1% |
| Q3 2020 | $116,853,000 | +26.0% | 542,670 | +3.4% | 0.60% | -1.2% |
| Q2 2020 | $92,769,000 | +385.4% | 524,624 | +280.0% | 0.60% | +290.3% |
| Q1 2020 | $19,111,000 | +2398.2% | 138,076 | +2505.2% | 0.16% | +3000.0% |
| Q3 2019 | $765,000 | -89.6% | 5,300 | -89.7% | 0.01% | -87.2% |
| Q2 2019 | $7,366,000 | -74.8% | 51,536 | -80.8% | 0.04% | -67.5% |
| Q3 2018 | $29,197,000 | +1379.1% | 268,700 | +1243.5% | 0.12% | +1400.0% |
| Q2 2018 | $1,974,000 | -91.1% | 20,000 | -91.1% | 0.01% | -91.3% |
| Q1 2018 | $22,118,000 | -15.2% | 225,900 | -19.6% | 0.09% | -18.6% |
| Q4 2017 | $26,093,000 | -88.4% | 281,112 | -89.3% | 0.11% | -88.8% |
| Q3 2017 | $225,332,000 | +283.0% | 2,626,865 | +276.8% | 1.01% | +204.8% |
| Q2 2017 | $58,829,000 | +13.9% | 697,114 | +5.1% | 0.33% | -8.6% |
| Q4 2016 | $51,631,000 | +94.8% | 663,300 | +96.2% | 0.36% | +94.1% |
| Q3 2016 | $26,504,000 | +75.7% | 338,100 | +126.4% | 0.19% | +80.6% |
| Q2 2016 | $15,086,000 | +51.5% | 149,367 | +42.3% | 0.10% | +35.5% |
| Q1 2016 | $9,960,000 | -73.9% | 105,000 | -74.4% | 0.08% | -75.8% |
| Q4 2015 | $38,099,000 | -6.5% | 410,200 | -14.2% | 0.31% | -1.9% |
| Q3 2015 | $40,730,000 | -55.6% | 478,000 | -55.4% | 0.32% | -49.7% |
| Q2 2015 | $91,817,000 | +73.7% | 1,072,755 | +72.3% | 0.64% | +76.7% |
| Q1 2015 | $52,867,000 | +50.6% | 622,700 | +52.0% | 0.36% | +46.3% |
| Q4 2014 | $35,107,000 | +27.6% | 409,600 | +13.1% | 0.25% | +18.8% |
| Q3 2014 | $27,512,000 | +92.9% | 362,100 | +99.8% | 0.21% | +127.5% |
| Q2 2014 | $14,266,000 | – | 181,200 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |